Beyond Diagnostics Ranks in the Top 5 Digital Health Innovators by Innosuisse

We’re thrilled to announce that Beyond Diagnostics, our pioneering startup, has been recognized as one of the top five innovators out of 100 in the Digital Health Nation, a prestigious initiative supported by Innosuisse. This recognition marks a major milestone in our journey to transform diabetes management with our breakthrough Point-of-Care (POC) solution, designed to monitor insulin activity in real time.

At Beyond Diagnostics, we’re addressing a critical yet often overlooked challenge in diabetes care: insulin instability during home storage. Our revolutionary POC test, built on advanced lateral flow assay (LFA) technology and enhanced by AI-driven analysis, aims to empower patients by providing accurate, instant insights into insulin activity. We’re not just helping to improve individual care but striving to impact global diabetes management.

The Digital Health Nation recognition reflects Innosuisse's commitment to accelerating high-potential, patient-centered innovations that can change lives. This ranking validates our vision and approach, as we bring together an incredible network of partners, including CSEM, alongside the critical support from Innosuisse.

We are immensely grateful for this acknowledgment and excited to be part of Switzerland's vibrant ecosystem for digital health innovation. As we advance our mission with the support of programs like the Digital Health Nation and the DayOne program, we remain committed to making a real difference for patients worldwide.